Diabetes data management company Tidepool is one of nine companies working with the FDA as part of the agency’s digital health pre-certification pilot program. In a blog post published yesterday, the company’s founder, president & CEO wrote that he hopes industry works to keep up with the evolving regulatory landscape and that the FDA should work to make its pre-certification process scalable to companies of all sizes.
The chief exec, Howard Look, specifically noted that he has urged the agency to ensure that any pre-certification process open to companies like Apple (NSDQ:AAPL) also be available to open-source diabetes projects.
Get the full story at our sister site, Drug Delivery Business News.